National Health Investors, Inc. (NYSE:NHI) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of National Health Investors, Inc. (NYSE:NHI) have earned an average rating of “Moderate Buy” from the eight brokerages that are presently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, five have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $84.5714.

NHI has been the subject of several recent research reports. BMO Capital Markets reduced their price target on National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a research report on Monday, June 15th. Cantor Fitzgerald reissued an “overweight” rating and issued a $94.00 price target on shares of National Health Investors in a research report on Wednesday, April 22nd. Wells Fargo & Company reduced their price target on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research report on Monday, June 1st. Weiss Ratings lowered National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Finally, Truist Financial reduced their target price on National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a research report on Friday, June 12th.

National Health Investors Trading Up 3.1%

NHI opened at $75.31 on Thursday. The firm has a market cap of $3.65 billion, a price-to-earnings ratio of 24.29, a PEG ratio of 3.92 and a beta of 0.52. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83. National Health Investors has a 12 month low of $67.94 and a 12 month high of $91.38. The stock has a fifty day moving average price of $75.22 and a 200-day moving average price of $79.68.

National Health Investors (NYSE:NHI) last released its quarterly earnings results on Monday, May 4th. The real estate investment trust reported $0.82 EPS for the quarter, missing the consensus estimate of $1.21 by ($0.39). The company had revenue of $115.13 million during the quarter, compared to the consensus estimate of $70.22 million. National Health Investors had a return on equity of 9.82% and a net margin of 36.86%.The company’s revenue was up 28.9% on a year-over-year basis. During the same period in the previous year, the firm posted $1.15 earnings per share. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, equities research analysts anticipate that National Health Investors will post 4.93 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Tuesday, June 30th will be given a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a yield of 4.9%. The ex-dividend date of this dividend is Tuesday, June 30th. National Health Investors’s dividend payout ratio is currently 118.71%.

Insider Activity

In other National Health Investors news, Director Robert A. Mccabe, Jr. bought 890 shares of National Health Investors stock in a transaction that occurred on Monday, June 15th. The shares were bought at an average cost of $71.65 per share, with a total value of $63,768.50. Following the transaction, the director directly owned 44,159 shares of the company’s stock, valued at approximately $3,163,992.35. This represents a 2.06% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO D. Eric Mendelsohn bought 1,500 shares of National Health Investors stock in a transaction that occurred on Friday, June 5th. The shares were acquired at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the transaction, the chief executive officer directly owned 133,316 shares in the company, valued at $9,177,473.44. This represents a 1.14% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 2.70% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Renaissance Group LLC increased its position in National Health Investors by 3.8% during the 4th quarter. Renaissance Group LLC now owns 3,206 shares of the real estate investment trust’s stock valued at $245,000 after buying an additional 117 shares in the last quarter. GAMMA Investing LLC grew its stake in National Health Investors by 41.8% during the 4th quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock valued at $35,000 after purchasing an additional 136 shares during the last quarter. Captrust Financial Advisors grew its stake in National Health Investors by 1.7% during the 4th quarter. Captrust Financial Advisors now owns 8,907 shares of the real estate investment trust’s stock valued at $680,000 after purchasing an additional 146 shares during the last quarter. EverSource Wealth Advisors LLC grew its stake in National Health Investors by 34.3% during the 1st quarter. EverSource Wealth Advisors LLC now owns 626 shares of the real estate investment trust’s stock valued at $51,000 after purchasing an additional 160 shares during the last quarter. Finally, Assetmark Inc. grew its stake in National Health Investors by 13.5% during the 1st quarter. Assetmark Inc. now owns 1,356 shares of the real estate investment trust’s stock valued at $110,000 after purchasing an additional 161 shares during the last quarter. 62.51% of the stock is owned by institutional investors and hedge funds.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.